Tennant Company (TNC) 2025 Annual Report Summary
Business Context and Reporting Period
This summary covers the Form 10-K for the fiscal year ended December 31, 2025. Tennant Company is a global leader in designing, manufacturing, and marketing floor maintenance and cleaning equipment, including autonomous robotic solutions. The company operates in three geographic regions: Americas, Europe/Middle East/Africa (EMEA), and Asia Pacific (APAC). As of December 31, 2025, the company employed 4,484 people worldwide.
Key Financial Metrics
| Metric | 2025 | 2024 |
|---|---|---|
| Net Sales | $1,203.5 million | $1,286.7 million |
| Gross Profit | $484.3 million (40.2% margin) | $550.0 million (42.7% margin) |
| Operating Income | $68.3 million (5.7% margin) | $114.3 million (8.9% margin) |
| Net Income | $43.8 million | $83.7 million |
| Diluted EPS | $2.36 | $4.38 |
| Operating Cash Flow | $65.0 million | $89.7 million |
| Total Debt | $273.6 million | $199.5 million |
| Cash & Equivalents | $106.4 million | $99.8 million |
| Debt-to-Capital Ratio | 31.2% | 24.3% |
Material Changes vs. Prior Period
- Revenue Decline: Net sales decreased 6.5% year-over-year. This was driven by a 7.3% organic decline, primarily due to volume decreases in North America. The decline was exacerbated by a significant backlog reduction in the prior year and operational disruptions from a new ERP system implementation in Q4 2025.
- Margin Compression: Gross profit margin decreased 250 basis points to 40.2%. Contributing factors included volume deleverage, higher material costs, and operational inefficiencies linked to the ERP transition. Operating income dropped 40% to $68.3 million.
- Geographic Performance: Americas sales fell 10.9%, while EMEA sales grew 5.1% (aided by favorable currency and the TCS acquisition). APAC sales declined 3.5%.
- Legal Contingency: The company recorded an incremental $6.0 million expense in 2025 related to an intellectual property lawsuit (Oxygenator Water Technologies), bringing the total accrued liability to approximately $20.2 million pending appeal.
Guidance, Outlook, and Risks
- ERP Implementation Impact: The company implemented a new global ERP system in North America in November 2025. This caused order management and fulfillment disruptions in Q4 2025. Management expects operational inefficiencies and elevated support costs to persist into Q1 2026, with a two-week manufacturing shutdown in early January 2026 for inventory stabilization. Margins are expected to improve gradually through 2026 as the system stabilizes.
- Macro Risks: The company faces ongoing risks from tariffs, inflation, and geopolitical instability. A February 2026 Supreme Court decision regarding the authority to impose tariffs creates uncertainty regarding potential recoveries of tariffs paid in 2025.
- Capital Allocation: The company repurchased 1.11 million shares for $87.7 million in 2025. The annual dividend was increased to $1.195 per share (54th consecutive increase). A quarterly dividend of $0.31 was declared in February 2026.
Investor Verification Checklist
- ERP Stabilization: Verify the timeline for full ERP system stabilization and the extent of Q1 2026 operational impact on revenue and margins.
- Legal Exposure: Monitor the status of the appeal regarding the Oxygenator Water Technologies verdict and the potential for further liability adjustments.
- Tariff Implications: Assess the financial impact of the February 2026 Supreme Court ruling on previously paid tariffs and future trade policy.
- North America Demand: Confirm whether the volume decline in North America is a temporary result of the ERP transition or a structural shift in market demand.
- Debt Levels: Review the increase in total debt (from $199.5M to $273.6M) and the company's ability to service this debt while maintaining dividend growth and share repurchases.